ArticleCancer research2025

Stimulating Soluble Guanylyl Cyclase with the Clinical Agonist Riociguat Restrains the Development and Progression of Castration-Resistant Prostate Cancer.

Ling Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.